Alternative first exons for GNAS transcripts lead to distinct products, which in human have been linked to osteodystrophy and pseudohypoparathyroidism phenotypes, while in mouse GNAS heterozygous mutants show metabolic abnormalities and insulin hypersensitivity (see Glycolysis above). Here, GNAS is linked to pseudohypoparathyroidism.